Executive hire signals shift toward commercial execution

Enovix (ENVX) has drawn fresh attention after appointing Steve Bakos as Senior Vice President of Worldwide Sales, a new role that aligns with its push toward commercializing 100% silicon-anode batteries.

Bakos, who brings more than 35 years of global semiconductor sales experience and prior leadership at Infineon Technologies and several other chip companies, is joining as Enovix ramps its silicon-enhanced product line from Korea and targets broader consumer and industrial adoption.

At a share price of $6.42, Enovix has a 30 day share price return of 15.47%, a year to date share price return of 18.63%, and a 3 year total shareholder return of 49.57%, pointing to recent momentum after a tougher longer stretch.

If you are looking beyond Enovix for other battery and electrification ideas, this is a good moment to scan companies tied to grid upgrades and electrification in the 36 power grid technology and infrastructure stocks

With the stock at $6.42, a reported intrinsic discount of 82% and a value score of 2, you have to ask: is Enovix still underappreciated by the market, or is the share price already reflecting future growth?

Most Popular Narrative: 56% Undervalued

With Enovix closing at $6.42 versus a narrative fair value of $14.45, the widely followed story centers on high growth expectations backed by aggressive capacity plans.

Completion of the site acceptance testing for the high-volume manufacturing line in Malaysia is set to boost production capacity and support significant revenue growth, with a focus on readiness for smartphone mass production in the fourth quarter of 2025. Successful shipment of early engineering smartphone battery samples and positive safety test results indicate future revenue increase potential, pending successful customer qualification for anticipated commercial smartphone launches in 2025.

Curious what kind of revenue ramp, margin shift, and future earnings multiple need to line up for that valuation? The full narrative spells out those assumptions in detail.

Result: Fair Value of $14.45 (UNDERVALUED)

However, this story can change quickly if high capital spending strains cash flow, or if smartphone qualifications and volume production slip beyond the current timelines investors are watching.

Another lens on valuation: revenue multiples look stretched

While the SWS DCF model points to Enovix trading 81.7% below its estimated future cash flow value of $35.09, the current P/S ratio of 42.9x tells a very different story, looking expensive versus the US Electrical industry at 2.8x and an estimated fair ratio of 14.1x. Which signal do you trust more when so much hinges on future execution?

Next Steps

With sentiment divided between upside potential and execution risk, this is a good time to review the numbers yourself and stress test the story. To see what is supporting the optimistic view, take a closer look at the 2 key rewards

Looking for more investment ideas?

Do not stop at a single stock when there are plenty of other opportunities you can scan quickly, compare side by side, and keep on your radar.

• Target stocks that combine quality with appealing valuations by reviewing the 51 high quality undervalued stocks.
• Prioritise sleep at night potential by checking companies that appear in the 71 resilient stocks with low risk scores.
• Hunt for under followed opportunities with strong fundamentals using the screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.